Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
4.980
+0.070 (1.43%)
Aug 27, 2026, 10:08 AM EDT - Market open
Verrica Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Verrica Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $14.8. The average 1-year stock price forecast is 197.19% higher than the current stock price, while the lowest is $10 (+100.80%) and the highest is $20 (+301.61%).
Price Target: $14.8 (+197.19%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Verrica Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Initiates $9 | Buy | Initiates | $9 | +80.72% | Aug 27, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +140.96% | Aug 7, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $20 | Buy | Reiterates | $20 | +301.61% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
24.87M
from 35.58M
Decreased by -30.09%
Revenue Next Year
39.69M
from 24.87M
Increased by 59.56%
EPS This Year
-2.01
from -1.24
EPS Next Year
-1.47
from -2.01
EPS and Forward PE are based on non-GAAP adjusted numbers.